ARCHIVES

Imbruvica Improves PFS, OS In Phase III CLL Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010

NEJM Does About-Face, Issues Correction On CT Lung Cancer Screening Study.

April 4, 2008

Soviet Exchanges Rise And Fall With Politics

August 23, 1991

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

Marc Lippman To Leave Georgetown For Michigan To Head Internal Medicine; Five Named To DCLG.

September 15, 2000

Amgen, J&J Defend ESA Indications.

March 21, 2008